Will Earnings Beat Estimates? Aptose Biosciences Inc (APTO) Stock

Cantor Fitzgerald raised the price target for the Aptose Biosciences Inc (NASDAQ:APTO) stock to “an Overweight”. The rating was released on October 19, 2020, according to finviz. Historical Earnings Surprises and Revenue Forecasts Profit is the most critical financial performance measure. Every investor in a business is looking forward to the earnings report as stock […]